
ESSA Pharma Inc.
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company was incorporated in 2009 and is headquartered in Vancouver, Canada. As of October 9, 2025, ESSA Pharma Inc. operates as a subsidiary of Alexis Bio, Inc.
Stock Performance
Stock price data not yet populated
Symbol: EPIX
Layoff History
Recent News
Other Biotechnology Companies
View All →Frequently Asked Questions
Has ESSA Pharma Inc. had layoffs?
How many employees does ESSA Pharma Inc. have?
What industry is ESSA Pharma Inc. in?
Is ESSA Pharma Inc. a publicly traded company?
Where is ESSA Pharma Inc. headquartered?
Disclaimer
Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.
This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.
Found an error? Report it here.